Twitter | Search | |
Search Refresh
Brad Loncar Apr 17
Reply Retweet Like
Tatiana Prowell, MD Apr 18
The iPlanner for is out. View abstracts & make your schedule here: . As always, more high-quality science & education than hours in the mtg. Congrats to hardworking ASCO staff & committee members on assembling a great mtg! Can’t wait!
Reply Retweet Like
Rafeh Naqash, MD Apr 20
Please come check out these posters at if you are around. Some provocative molecular data. Watch out for the " resuming IO after colitis" a big multicenter effort that will soon be out as a manuscript.
Reply Retweet Like
Mandy Davis Aitken 6h
Tip: Register by 4/24 (this Wed.) at to have your badge mailed to you and skip badge pickup lines. Now arrival requires just three steps: 1) Download the iPlanner 2) Pick up a lanyard at any info desk 3) Head to your first session
Reply Retweet Like
ASCO Apr 16
. congratulates the recipients of the Merit Awards
Reply Retweet Like
Natasha Dhawan, MD 3h
Eek!! is the same weekend as my grad. After missing countless 🎂, weddings, etc, what’s 1️⃣ more in the name of professional growth? Sadly, it barely fazes me anymore... Anyone else feel this way?
Reply Retweet Like
orbytelgroup Apr 18
- List of all 2,365 Abstract Titles in XLS (as of Apr 18). Makes it easier to search and find relevant ASCO 2019 content. Please DM or click here:
Reply Retweet Like
Jacob Plieth Apr 17
Replying to @BursatilBiotech
Yes, but important now because of the CVR. titles suggest we're not getting an efficacy update on Transcend lymphoma cohort
Reply Retweet Like
Ricardo Carvalho Apr 16
It seems that we’re going to have a pancreas session at this year's ASCO plenary: POLO trial (Olaparib maintenance)!
Reply Retweet Like
Gene Editing by Zinc Finger 🖕 Apr 16
allogeneic car-t KITE-037 Asco abstracts tomorrow
Reply Retweet Like
DotVenky Apr 12
Replying to @ASCO
i thought regular abstract titles will be released on April 17. would it include late-breaking titles as well?
Reply Retweet Like
Dr Sunil Verma Apr 18
ASCO Announces Top Studies to Be Presented at 2019 Annual Meeting | ⁦
Reply Retweet Like
Ishwaria Subbiah, MD MS Apr 18
Replying to @mtmdphd @ASCO
Keep us posted!
Reply Retweet Like
Jacob Plieth Apr 17
Reply Retweet Like

Related searches

@asco
Seth Pollack Apr 18
oooh, been waiting for this: Poster Board: #338 • Abstract 11015 Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts.
Reply Retweet Like
Breelyn Wilky, MD Apr 17
Ok... I had tweeted that was the most important data to review at - but had no idea it would make the plenary. Congratulations ⁦⁩! So important for particularly in light of TRC105. Thanks ⁦⁩ for the find!
Reply Retweet Like
ASCO Apr 18
We've announced the top studies that will be highlighted in the Press Program:
Reply Retweet Like
(((Dieter Hovekamp))) Apr 18
Replying to @biobuddha @sunrgu
Reply Retweet Like
Armin Shahrokni Apr 17
I am very thankful to for giving platform for back2back oral presentations on . 6/3, will talk about GOSAFE study, and then I present our data on "Reduced 90day postoperative mortality through Geriatric Comanagement " for pts. Exciting...
Reply Retweet Like
Lorenzo Gerratana 7h
Treatment resistance is just part of the story: changes in may affect its phenotype suggesting the need for a -driven monitoring strategy
Reply Retweet Like